Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$11.48 - $15.86 $14,074 - $19,444
-1,226 Reduced 1.27%
95,008 $1.24 Million
Q4 2023

Feb 09, 2024

BUY
$6.03 - $12.88 $31,753 - $67,826
5,266 Added 5.79%
96,234 $1.23 Million
Q3 2023

Nov 13, 2023

BUY
$12.16 - $24.87 $486,983 - $995,993
40,048 Added 78.65%
90,968 $1.19 Million
Q2 2023

Aug 10, 2023

BUY
$23.91 - $27.81 $444,869 - $517,432
18,606 Added 57.58%
50,920 $1.3 Million
Q1 2023

May 09, 2023

BUY
$20.23 - $26.22 $177,659 - $230,264
8,782 Added 37.32%
32,314 $813,000
Q4 2022

Feb 10, 2023

BUY
$20.54 - $24.67 $483,347 - $580,534
23,532 New
23,532 $541,000

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $423M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.